ACM
AMGN icon

Ayrshire Capital Management’s Amgen AMGN Stock Holding History

Ayrshire Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,712
Closed -$1.59M – 48
2025
Q2 		$1.59M Buy
5,712
+106
+2% +$30K 0.77% 32
2025
Q1 		$1.75M Buy
5,606
+1,591
+40% +$470K 0.85% 28
2024
Q4 		$1.05M Buy
4,015
+122
+3% +$36.2K 0.51% 34
2024
Q3 		$1.25M Buy
3,893
+57
+1% +$18.6K 0.6% 36
2024
Q2 		$1.2M Buy
3,836
+100
+3% +$29.4K 0.61% 35
2024
Q1 		$1.06M Buy
3,736
+190
+5% +$55.6K 0.57% 34
2023
Q4 		$1.02M Buy
3,546
+62
+2% +$16.9K 0.59% 36
2023
Q3 		$936K Sell
3,484
-2
-0.1% -$499 0.61% 36
2023
Q2 		$794K Buy
3,486
+134
+4% +$31.1K 0.5% 35
2023
Q1 		$810K Sell
3,352
-2
-0.1% -$491 0.55% 36
2022
Q4 		$881K Buy
3,354
+67
+2% +$18K 0.62% 36
2022
Q3 		$741K Buy
3,287
+239
+8% +$57.9K 0.55% 36
2022
Q2 		$741K Sell
3,048
-306
-9% -$75K 0.52% 38
2022
Q1 		$811K Buy
3,354
+380
+13% +$87.3K 0.48% 40
2021
Q4 		$669K Buy
2,974
+27
+0.9% +$5.7K 0.34% 41
2021
Q3 		$627K Buy
2,947
+90
+3% +$20.7K 0.36% 42
2021
Q2 		$696K Buy
2,857
+75
+3% +$18.4K 0.39% 44
2021
Q1 		$692K Buy
2,782
+9
+0.3% +$2.15K 0.42% 42
2020
Q4 		$638K Buy
2,773
+601
+28% +$139K 0.41% 46
2020
Q3 		$552K Buy
2,172
+334
+18% +$82.7K 0.4% 48
2020
Q2 		$433K Sell
1,838
-956
-34% -$218K 0.36% 50
2020
Q1 		$567K Buy
2,794
+297
+12% +$64.9K 0.57% 45
2019
Q4 		$602K Buy
+2,497
New +$550K 0.5% 51

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ayrshire Capital Management's AMGN Position: Q3 2025 in Review

Ayrshire Capital Management sold out of Amgen (AMGN) in Q3 2025, closing a stake of 5,712 shares — an estimated $1.59M sold.

Ayrshire Capital Management first reported a position in AMGN in Q4 2019 and held it in 23 quarters. The position peaked at $1.75M in Q1 2025. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Ayrshire Capital Management reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • Ayrshire Capital Management sold 5,712 Amgen shares in Q3 2025, an estimated $1.59M.
  • Ayrshire Capital Management first reported a position in Amgen in Q4 2019 and held it in 23 quarters.
  • Ayrshire Capital Management's Amgen position peaked at $1.75M in Q1 2025.
  • 2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Ayrshire Capital Management's 13F filing for Q3 2025, filed 20 Oct 2025.